Emma Rossi, MD
Gynecologic Oncology · Greensboro, NCNPI 1215198080
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $57,156, more than ten times the $193 reported in 2019.
Across 116 payments — averaging $533.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$43K
- Intuitive Surgical$19K
- Baxter Healthcare$262
- GSK$111
- AstraZeneca$43
Across 2 payments — averaging $138,707 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$277K
What the payments were for
- Consulting fees$1,2502%
- Speaking & faculty fees$35,68358%
- Travel & lodging$9,09915%
- Food & beverage$3,0795%
- Education$12,64320%
- Gifts$1700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 56 | $42,846 |
| Intuitive Surgical | 56 | $18,662 |
| Baxter Healthcare | 2 | $262 |
| GSK | 1 | $111 |
| AstraZeneca | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$17,511
- TISSEEL$262
- JEMPERLI$111
- LigaSure$101
How this compares
$61,923 in reported general payments places this provider in the 85th percentile of 52 gynecologic oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $13,669 |
| Dexamethasone | 13 | $258 |
| Ondansetron Hcl | 18 | $97 |
| Prochlorperazine Maleate | 12 | $84 |
| Duloxetine Hcl | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Greensboro
- Daniel Clarke-PearsonGreensboro$18
- Lucybeth Nieves ArribaWilmington$251K
- Robert NaumannCharlotte$221K
- Angeles SecordDurham$121K
- Erin CraneCharlotte$98K
- Michael SundborgSouthern Pines$85K
- William LoweryDurham$67K
- Jubilee BrownCharlotte$44K
- Victoria Bae-JumpChapel Hill$19K
- Andrew BerchuckDurham$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.